An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Axon Enterprise, Inc.
VERDICT
The label
Markup
read at $525.48
Axon Enterprise holds its Markup at $525.48.
PHPhase · the trend structure carries the Markup label
INInsiders · no filings inside 60 days, left as found
POPositioning · no disclosures inside 60 days, left as found
OPOptions · no verdict drawn today, left as found
SCScreen · does not pass the values gate
edge confirmed
edge broken
edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
INVESTOR
The investor read · the season, not the day
As held on the ledger · 2026-07-27
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 8 days
Price
$525.48
Valuation
213.61 trailing · 49.97 forward price to earnings
Values screen
FAIL· score 10.0
Beta
1.38
OPPORTUNITY
The opportunity · what the numbers say it is worth
Our framework reads AVOID — it trades above our $455.16 fair value estimate, narrow competitive moat, 33.70% revenue growth.
Read at
$525.48
213.61 P/E · 49.97 fwd
Our fair value
$455.16
13% premium
Analyst target (avg)
$700.00
+33% to current
Target low $409.68Analyst target rangeTarget high $825.00
▲ current $525.48 · | average target
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Current
$525.48
you are here
Conservative
$368.71
-30%
Analyst avg
$700.00
+33%
Our fair value
$455.16
-13%
Analyst high
$825.00
+57%
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish — a quality-at-a-fair-price name rather than a deep-value one.
Revenue growth
33.70%
Profit margin
6.91%
Debt to equity
52.07
Analyst consensus
Buy · 19 covering
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
SCREEN
The values screen, explained · five checks, plain English
This company is excluded by both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. It fails on both:
The common standard· AAOIFI Used by most halal investing apps✗ DOES NOT PASS
Our stricter standard· asset-based The one Titan applies✗ DOES NOT PASS
Why it fails. The problem is its business activity screen. Because both standards agree on this, it is a clear exclusion, not a borderline case.
Business activityBusiness activity: Aerospace & DefenseFail
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
PLAIN
The business, in plain words · what the numbers mean
Bodycam Firm Trips Over Ethical Red Line
Every officer who clips on a bodycam or reaches for a conducted energy device feeds revenue into Axon. The company sits at the centre of that public safety stack, posting 34% revenue growth and a narrow moat built on hardware plus cloud software.
We pass. The business fails the ethical screen outright. On top of that the shares trade at a 48.3 times forward multiple and sit 11% above our fair value of 455 dollars, leaving little room for error even if growth holds.
Low returns on equity at 7% and thin 7% profit margins already signal limited pricing power. Analyst targets at 700 dollars ignore both the valuation gap and the ethical block. Analysis, not advice.
Screened names in the same industry · explore each on its own page.
TRADE
Where & how to trade · wherever in the world you are
AXON trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
TRADER
The trader read · the latest dated commentary
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 5.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 41%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (18 analysts) rates it buy, with a mean price target of $662. Entered 2026-07-22 · Distribution
JOURNAL
The dated journal · newest first, never edited
2026-07-22Distribution$510.28+5.0%Entry 4
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 5.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 41%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (18 analysts) rates it buy, with a mean price target of $662.
2026-07-18Distribution$486.12+0.0%Entry 3
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 41%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (18 analysts) rates it buy, with a mean price target of $662.
2026-07-03Distribution$486.12+0.0%Entry 2
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02Distribution$486.12Entry 1
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
